Related Experiment Video
Updated: May 14, 2026

08:19
Hollow Microneedle-based Sensor for Multiplexed Transdermal Electrochemical Sensing
Published on: June 1, 2012
A smart closed-loop microneedle system for self-regulated blood glucose management.
1Beijing Institute of Radiation Medicine, Beijing, 100850, China; Shenyang No.22 High School, Shenyang, Liaoning, 110075, China.
Biosensors & Bioelectronics
|May 12, 2026
Summary
A new closed-loop system offers improved blood-glucose management for diabetes patients. This innovative device integrates sensing and drug delivery via microneedles, reducing patient intervention and waste.
Area of Science:
- Biomedical Engineering
- Diabetes Technology
- Microneedle Technology
Background:
- Effective glycemic control is crucial for managing diabetes.
- Current methods like glucose meters and injections have limitations, including infection risk and waste generation.
- A need exists for less invasive and more automated diabetes management solutions.
Purpose of the Study:
- To develop and present a user-friendly, closed-loop blood-glucose management system.
- To integrate glucose sensing and controllable drug delivery into a single device.
- To establish an engineering framework for future closed-loop glucose management.
Main Methods:
- Development of a dual-mode microneedle array integrating a glucose sensor and drug-release module.
- Coupling the microneedle array with a miniature electrochemical workstation for real-time monitoring and delivery.
- Testing the system in preliminary proof-of-concept studies using diabetic mouse models.
Main Results:
- The integrated system demonstrated potential for dynamic glucose monitoring and precise drug delivery.
- Positive trends in relevant data were observed in diabetic mouse models.
- The system design facilitates stable glycemic control with minimal patient intervention.
Conclusions:
- The developed system offers a promising approach to closed-loop glucose management.
- This work provides a technical foundation for advancing mid-to-long-term closed-loop diabetes care.
- The microneedle-based bioelectronic device framework minimizes patient intervention and medical waste.
Related Concept Videos
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
Feedback Loops
In most cases, excessive hormone production is prevented by negative feedback—a loop that starts with a stimulus inducing the release of a particular substance, like a hormone, to maintain a certain level before triggering a signal that results in a decrease in further release of the hormone.
